A comparative study of confidence intervals to assess biosimilarity from analytical data.

Howe's method Wald-type confidence intervals biosimilarity confidence interval exact-based intervals generalized confidence intervals

Journal

Pharmaceutical statistics
ISSN: 1539-1612
Titre abrégé: Pharm Stat
Pays: England
ID NLM: 101201192

Informations de publication

Date de publication:
05 2019
Historique:
received: 03 07 2018
revised: 22 10 2018
accepted: 04 12 2018
pubmed: 16 1 2019
medline: 18 2 2020
entrez: 16 1 2019
Statut: ppublish

Résumé

Assessment of analytical similarity of tier 1 quality attributes is based on a set of hypotheses that tests the mean difference of reference and test products against a margin adjusted for standard deviation of the reference product. Thus, proper assessment of the biosimilarity hypothesis requires statistical tests that account for the uncertainty associated with the estimations of the mean differences and the standard deviation of the reference product. Recently, a linear reformulation of the biosimilarity hypothesis has been proposed, which facilitates development and implementation of statistical tests. These statistical tests account for the uncertainty in the estimation process of all the unknown parameters. In this paper, we survey methods for constructing confidence intervals for testing the linearized reformulation of the biosimilarity hypothesis and also compare the performance of the methods. We discuss test procedures using confidence intervals to make possible comparison among recently developed methods as well as other previously developed methods that have not been applied for demonstrating analytical similarity. A computer simulation study was conducted to compare the performance of the methods based on the ability to maintain the test size and power, as well as computational complexity. We demonstrate the methods using two example applications. At the end, we make recommendations concerning the use of the methods.

Identifiants

pubmed: 30644636
doi: 10.1002/pst.1925
doi:

Substances chimiques

Biosimilar Pharmaceuticals 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

316-328

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Jorge Quiroz (J)

Merck & Co. Inc., Research CMC Statistics Kenilworth, NJ, USA.

Richard Montes (R)

Pfizer Inc., Biosimilar Pharmaceutical Sciences Lake Forest, IL, USA.

Heliang Shi (H)

Pfizer Inc., Biosimilar Pharmaceutical Sciences Lake Forest, IL, USA.

Satrajit Roychoudhury (S)

Pfizer, Inc., Global Biometrics & Data Management Peapack, NJ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH